Nautilus Biotechnology (NAUT) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Nautilus Biotechnology (NAUT) has outperformed Rapid Micro Biosystems (RPID) over the past year, gaining 126.3% versus a loss of 75.7%. Over five years, NAUT leads with a -65.7% price change compared with -94.7% for RPID. Nautilus Biotechnology is the larger company by market cap ($231.6 million vs $43.2 million), about 5.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NAUT | RPID |
|---|---|---|
| Share price | $1.82 | $0.8617 |
| Market cap | $231.60M | $43.22M |
| 1-day change | -7.14% | -4.01% |
| YTD return | +0.51% | -69.04% |
| 1-year return | +126.33% | -75.67% |
| 5-year return | -65.67% | -94.66% |
| EPS (TTM) | $-0.45 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.31 | $4.94 |
| 52-week low | $0.82 | $0.826 |
| Distance from 52-week high | -57.77% | -82.56% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +110.44% | — |
| Average volume | 2.59M | 271.81K |
| Shares outstanding | 127.26M | 45.66M |
| Employees | 127 | — |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nautilus Biotechnology is about 5.4 times larger than Rapid Micro Biosystems by market value ($231.60M vs $43.22M).
- NAUT has outperformed RPID by 202.0 percentage points over the past year.
About Nautilus Biotechnology
NAUT stock →Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis.
Industrials · Biotechnology: Laboratory Analytical Instruments · 127 employees
NAUT vs RPID FAQ
Which is bigger, Nautilus Biotechnology or Rapid Micro Biosystems?
Nautilus Biotechnology (NAUT) is larger, with a market capitalization of $231.60M compared with $43.22M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, NAUT or RPID?
NAUT returned +126.33% over the past 12 months, compared with -75.67% for RPID (price return, excluding dividends). Past performance does not predict future results.
Are Nautilus Biotechnology and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.